HomeAI · summaries
Storia in 9 fonti
Gauteng targets 56,000 people as new twice-yearly Lenacapavir HIV prevention rolls out across 133 clinics
Gauteng is set to roll out Lenacapavir, a new long-acting HIV prevention injection, targeting over 56,000 individuals at high risk of HIV infection.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
businessday.co.za
Ramaphosa urged to press for wider access to Gilead’s HIV shot in SA
Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir
- ·
morningstar.com
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
